Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)A Proof of Concept Study to Evaluate CN-105 in ICH Patients
- First Posted Date
- 2017-05-30
- Last Posted Date
- 2020-03-11
- Lead Sponsor
- AegisCN LLC
- Target Recruit Count
- 38
- Registration Number
- NCT03168581
- Locations
- 🇺🇸
A.B. Chandler Medical Center-University of Kentucky, Lexington, Kentucky, United States
🇺🇸Duke University Health System, Durham, North Carolina, United States
🇺🇸Wake Forest Baptist Health, Winston-Salem, North Carolina, United States
Safety Study of CN-105 Neuroprotective Peptide for Intracerebral Hemorrhage
- First Posted Date
- 2016-02-02
- Last Posted Date
- 2016-08-18
- Lead Sponsor
- AegisCN LLC
- Target Recruit Count
- 48
- Registration Number
- NCT02670824
- Locations
- 🇺🇸
Duke Clinical Research Institute, Durham, North Carolina, United States
News
No news found